067080 fundamentals
Key facts
DAE HWA PHARM Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Pharmaceuticals manufacturing and distribution, Pharmaceuticals Wholesale, and Pharmaceuticals Materials manufacturing and distribution. Its products include cough suppressants, expectorants, mucolytics, drugs affecting the nervous system, drugs for liver diseases, corticosteroids and hemorrhoid disease, analgesics, anti-inflammatory, anti-pyretics, vitamins and tonics, plaster, antihistamines, skeletal muscle relaxants, cardiovascular drugs, anti-inflammatory enzymes, gastro-intestinal drugs, iron and calcium supply, topical drugs, and injections. The company was founded by Kim Ki-Yong on January 1, 1984 and is headquartered in Hoengseong-gun, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company